Dr Rabia Mukadam(PhD)
Dr Rabia Mukadam(PhD)is a Molecular Scientist currently heading the Molecular Department of Pathologists Lancet Kenya, Nairobi.
She completed her undergraduate degrees at the University of Cape Town in Medical Biochemistry, and her postgraduate degree as a Gates Malaria Partnership Doctoral Student at the University of Liverpool, School of Tropical Medicine where she received a PhD in Molecular and Biochemical Parasitology.
She has spent most of her career in research working with the Malawi Research Institute, with whom she has remained linked to date, where she has collaborated with other research bodies such as Wellcome Trust, NIH, and Walter Reed, where she spent time in Maryland at John Hopkins, School of Public Health and University of Maryland, Centre for Vaccine Development.
Currently overseeing the Molecular department at PLK, she has spearheaded the setting up of KRAS, EGFR, BRAF and other ongonetics at the Lancet’s main reference laboratory in Nairobi, and was behind the setting up of HPV testing for primary cervical cancer screening on COBAS 4800 in 2016, being one of the first laboratories worldwide to introduce the test for primary cervical screening on self-collected samples.
A mother of three, her interests include application of molecular tests for diagnostics and wellness investigation including use of NAATS for asymptomatic sexually transmitted infections, genetic screening for inborn metabolic and neurological illnesses.
She is actively engaged in research for various groups who undertake research projects through Lancet, and is also active in teaching through continuous professional development presentations for various cadres of clinical personnel.